[EQ] Diabetes: cost of illness in Norway

Diabetes: cost of illness in Norway

Oddvar Solli1, Trond Jenssen2, 3, Ivar S Kristiansen 1, 4

1Department of Health Management and Health Economics,  Oslo, Norway

2Rikshospitalet University Hospital, Oslo, Norway

3Institute of Clinical Medicine, Medical Faculty, University of Tromsø, Norway

4Institute of Public Health, University of Southern Denmark, Denmark

BMC Endocrine Disorders - Volume 10

doi:10.1186/1472-6823-10-15 -  September 2010

Available online at: http://bit.ly/blvwVG

 

"….Diabetes mellitus places a considerable burden on patients in terms of morbidity and mortality and on society in terms of costs. Costs related to diabetes are expected to increase due to increasing prevalence of type 2 diabetes. The aim of this study was to estimate the health care costs attributable to type 1 and type 2 diabetes in Norway in 2005.

Methods

Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, medical equipment, nutrition guidance, physiotherapy, acupuncture, foot therapy and indirect costs were collected from national registers and responses to a survey of 584 patients with diabetes. The study was performed with a prevalence approach. Uncertainty was explored by means of bootstrapping.

Results

When hospital stays with diabetes as a secondary diagnosis were excluded, the total costs were €293 million, which represents about 1.4% of the total health care expenditure.
Pharmaceuticals accounted for €95 million (32%), disability pensions €48 million (16%), medical devices €40 million (14%) and hospital admissions €21 million (7%).

 

Patient expenditures for acupuncture, physiotherapy and foot therapy were many times higher than expenditure for nutritional guidance. Indirect costs (lost production from job absenteeism) accounted for €70.1 million (24% of the €293 million) and included sick leave (€16.7 million), disability support and disability pensions (€48.2 million) and other indirect costs (€5.3 million). If all diabetes related hospital stays are included (primary- and secondary diagnosis) total costs amounts to €535 million, about 2.6% of the total health care expenditure in Norway.

 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area]

"Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members".
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho

IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission. 

Thank you.

[EQ] Sub-national assessment of inequality trends in neonatal and child mortality in Brazil

Sub-national assessment of inequality trends in neonatal and child mortality in Brazil
 

Angelica Sousa^1,2 , Kenneth Hill² and Mario R Dal Poz³

¹  Initiative for Global Health, Harvard University, Cambridge, USA

²  Harvard Center for Population and Development Studies, Harvard University, Cambridge, USA

³  Department of Human Resources for Health, World Health Organization, Geneva, Switzerland

International Journal for Equity in Health
September 2010, 9:21doi:10.1186/1475-9276-9-21

Available online at: http://bit.ly/8Zy87K  

Objective:  
Brazil’s large socioeconomic inequalities together with the increase in neonatal mortality jeopardize the MDG-4 child mortality target by 2015. We measured inequality trends in neonatal and under five mortality across municipalities characterized by their socio-economic status in a period where major pro poor policies were implemented in Brazil to infer whether policies and interventions in newborn and child health have been successful in reaching the poor as well as the better off.

 

Methods: Using data from the 5,507 municipalities in 1991 and 2000, we developed accurate estimates of neonatal mortality at municipality level and used these data to investigate inequality trends in neonatal and under five mortality across municipalities characterized by socio-economic status.

 

Results: Child health policies and interventions have been more effective in reaching the better off than the worst off. Reduction of under five mortality at national level has been achieved by reducing the level of under five mortality among the better off. Poor municipalities suffer from worse newborn and child health than richer municipalities and the poor/rich gaps have increased.

 

Conclusion: Our analysis highlights the importance of monitoring progress on MDGs at sub-national level and measuring inequality gaps to accurately target health and inter-sectoral policies. Further efforts are required to improve the measurement and monitoring of trends in neonatal and under five mortality at sub-national level, particularly in developing countries and countries with large socioeconomic inequalities.

 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho

IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission. 

Thank you.

[EQ] New Directions in Welfare 2011 Congress OECD Paris France 6-8 July 2011

New Directions in Welfare 2011 Congress

OECD - Paris, France, 6-8 July 2011

Call for abstracts - Deadline 30 September 2010 - health econometrics and health economics

Website: http://bit.ly/cyBlnJ

 

“….In July 2011 at Paris, the range of papers and topics will follow a similar pattern to the Oxford Conference which was attended by over 130 economists and generated a special issue of the Journal of Public Economics in honor of Professor Amartya Sen.

 

We welcome contributions from theorists and empiricists alike who are interested in broadening our understanding of the economics of welfare which continues to flourish. Following work by Sen, Stiglitz and others that has helped to bring about the Sarkozy Report, the EU’s Beyond GDP memorandum and a number of other initiatives, the congress particularly welcomes papers relating to the theoretical or empirical economics of Health, Development, Social Policy, Environment, Labour, Education, Childhood, Aging, Migration, Culture, Happiness, Equality and Equity, Behavioural Economics and Life course issues – any area of economics, in fact, closely interested in understanding the economics of human welfare.

 

Previously nearly a third of papers came from the following areas where there will again be strands: Social Choice, Utility Theory, Experimental Economics and Philosophical Foundations of Economic Theory.

 

The meeting in Paris, France provides an exciting opportunity for economists in many branches of the profession to come together and consider the latest research much of which is contributing the improvement of public policy (a focus of day 1) in many fields and countries around the world whilst broadening the conceptual, technical and substantive knowledge of economic analysis. ….”

Tracks:

- Theory (e.g. Social Choice or Related Economic Theory)

- Applied (e.g. Health, Development, Environment, Social Policy, Education, Applied Econometrics)

 

 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho

IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission. 

Thank you.